GEHC
GE HealthCare Technologies Inc. NASDAQ Listed Dec 15, 2022$61.33
Mkt Cap $27.9B
52w Low $58.75
8.3% of range
52w High $89.77
50d MA $71.72
200d MA $76.24
P/E (TTM)
13.4x
EV/EBITDA
11.3x
P/B
2.6x
Debt/Equity
1.0x
ROE
17.9%
P/FCF
24.9x
RSI (14)
—
ATR (14)
—
Beta
1.31
50d MA
$71.72
200d MA
$76.24
Avg Volume
3.9M
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
500 West Monroe Street · Chicago, IL 60661 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | TNS | 1.07 | 0.99 | -7.5% | 59.49 | -0.5% | +2.3% | +2.6% | +2.5% | +2.6% | +3.8% | — |
| Feb 4, 2026 | TNS | 1.40 | 1.44 | +2.9% | 82.63 | -0.4% | -0.4% | -2.4% | -4.3% | -4.1% | -4.2% | — |
| Oct 29, 2025 | TNS | 1.05 | 1.07 | +1.9% | 77.38 | +0.0% | -3.1% | -3.1% | -3.8% | -4.0% | -2.3% | — |
| Jul 30, 2025 | TNS | 0.92 | 1.06 | +15.5% | 71.64 | +1.0% | -0.4% | -2.5% | -1.4% | -1.3% | -2.3% | — |
| Apr 30, 2025 | TNS | 0.91 | 1.01 | +10.5% | 70.33 | -0.0% | -3.8% | +0.3% | -1.4% | -4.6% | -2.1% | — |
| Feb 13, 2025 | TNS | 1.26 | 1.45 | +15.1% | 93.48 | -0.3% | -1.4% | -0.9% | -1.0% | -1.5% | -2.6% | — |
| Oct 30, 2024 | TNS | 1.05 | 1.14 | +8.6% | 87.20 | -1.2% | +0.2% | -0.3% | -0.2% | +1.1% | -0.5% | — |
| Jul 31, 2024 | TNS | 0.98 | 1.00 | +2.0% | 84.63 | -0.6% | -1.5% | -1.4% | -3.7% | -3.6% | -6.3% | — |
| Apr 30, 2024 | TNS | 0.91 | 0.90 | -1.1% | 76.24 | +0.4% | +2.6% | +2.1% | +4.2% | +4.7% | +6.8% | — |
| Feb 6, 2024 | TNS | 1.07 | 1.18 | +10.3% | 81.96 | +0.1% | -0.2% | +0.1% | -0.8% | +1.5% | +0.4% | — |
| Oct 31, 2023 | TNS | 0.90 | 0.99 | +10.0% | 66.57 | +0.3% | +2.6% | +4.0% | +7.5% | +6.8% | +6.2% | — |
| Jul 25, 2023 | TNS | 0.87 | 0.92 | +5.7% | 80.21 | +0.1% | -3.5% | -4.2% | -2.9% | -2.8% | -3.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 | Wells Fargo | Maintains | Overweight → Overweight | — | $59.49 | $59.21 | -0.5% | +2.3% | +2.6% | +2.5% | +2.6% | +3.8% |
| Apr 30 | Barclays | Maintains | Equal Weight → Equal Weight | — | $59.49 | $59.21 | -0.5% | +2.3% | +2.6% | +2.5% | +2.6% | +3.8% |
| Apr 30 | Citigroup | Maintains | Neutral → Neutral | — | $59.49 | $59.21 | -0.5% | +2.3% | +2.6% | +2.5% | +2.6% | +3.8% |
| Apr 30 | JP Morgan | Maintains | Neutral → Neutral | — | $59.49 | $59.21 | -0.5% | +2.3% | +2.6% | +2.5% | +2.6% | +3.8% |
| Apr 30 | Goldman Sachs | Downgrade | Buy → Neutral | $65 | $59.49 | $59.21 | -0.5% | +2.3% | +2.6% | +2.5% | +2.6% | +3.8% |
| Apr 30 | Evercore ISI | Maintains | Outperform → Outperform | — | $59.49 | $59.21 | -0.5% | +2.3% | +2.6% | +2.5% | +2.6% | +3.8% |
| Apr 29 | BTIG | Maintains | Buy → Buy | — | $68.50 | $62.15 | -9.3% | -13.2% | -11.2% | -10.9% | -10.9% | -10.9% |
| Apr 21 | BTIG | Maintains | Buy → Buy | — | $74.15 | $74.43 | +0.4% | -2.5% | -3.7% | -5.7% | -7.2% | -4.9% |
| Apr 17 | Piper Sandler | Maintains | Overweight → Overweight | — | $73.20 | $75.04 | +2.5% | +2.0% | +1.3% | -1.3% | -2.5% | -4.5% |
| Apr 13 | Mizuho | Maintains | Outperform → Outperform | — | $73.18 | $72.62 | -0.8% | +0.9% | +2.0% | +0.5% | +0.0% | +2.0% |
| Apr 9 | Goldman Sachs | Maintains | Buy → Buy | — | $73.75 | $72.74 | -1.4% | -1.1% | -0.8% | +0.1% | +1.2% | -0.3% |
| Apr 6 | Evercore ISI | Maintains | Outperform → Outperform | — | $70.35 | $70.35 | +0.0% | +0.1% | -0.9% | +4.8% | +3.6% | +4.0% |
| Mar 26 | Piper Sandler | Maintains | Overweight → Overweight | — | $72.20 | $71.76 | -0.6% | -0.9% | -4.1% | -4.8% | -1.4% | -0.3% |
| Mar 19 | BTIG | Maintains | Buy → Buy | — | $70.25 | $69.44 | -1.2% | +0.2% | -0.9% | +2.0% | +1.0% | +2.8% |
| Mar 11 | Citigroup | Maintains | Neutral → Neutral | — | $72.73 | $72.57 | -0.2% | -0.1% | -3.3% | -2.7% | -0.8% | -0.5% |
| Feb 9 | BTIG | Maintains | Buy → Buy | — | $80.65 | $80.00 | -0.8% | -1.9% | -1.8% | -1.8% | -2.5% | -0.4% |
| Feb 6 | Barclays | Maintains | Equal Weight → Equal Weight | — | $82.31 | $82.48 | +0.2% | -2.0% | -3.9% | -3.8% | -3.8% | -4.4% |
| Feb 5 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $82.63 | $82.32 | -0.4% | -0.4% | -2.4% | -4.3% | -4.1% | -4.2% |
| Feb 5 | Stifel | Maintains | Buy → Buy | — | $82.63 | $82.32 | -0.4% | -0.4% | -2.4% | -4.3% | -4.1% | -4.2% |
| Feb 5 | Wells Fargo | Maintains | Overweight → Overweight | — | $82.63 | $82.32 | -0.4% | -0.4% | -2.4% | -4.3% | -4.1% | -4.2% |
| Feb 5 | Evercore ISI | Maintains | Outperform → Outperform | — | $82.63 | $82.32 | -0.4% | -0.4% | -2.4% | -4.3% | -4.1% | -4.2% |
| Feb 4 | BTIG | Maintains | Buy → Buy | — | $78.78 | $79.71 | +1.2% | +4.9% | +4.5% | +2.4% | +0.4% | +0.6% |
| Jan 30 | Piper Sandler | Maintains | Overweight → Overweight | — | $78.78 | $78.66 | -0.2% | +0.2% | +1.7% | +0.0% | +4.9% | +4.5% |
| Jan 15 | UBS | Downgrade | Neutral → Sell | — | $85.30 | $84.21 | -1.3% | -3.3% | -4.2% | -7.6% | -4.9% | -4.0% |
| Jan 7 | Stifel | Maintains | Buy → Buy | — | $86.73 | $86.33 | -0.5% | -1.1% | +1.6% | +0.6% | +0.2% | -2.3% |
| Jan 5 | BofA Securities | Maintains | Neutral → Neutral | — | $82.82 | $82.79 | -0.0% | +2.7% | +4.7% | +3.5% | +6.4% | +5.4% |
| Dec 11 | Citigroup | Maintains | Neutral → Neutral | — | $84.47 | $84.47 | +0.0% | +1.9% | -0.6% | -0.0% | -2.6% | -2.5% |
| Dec 11 | Jefferies | Maintains | Buy → Buy | — | $84.47 | $84.47 | +0.0% | +1.9% | -0.6% | -0.0% | -2.6% | -2.5% |
| Nov 21 | BTIG | Maintains | Buy → Buy | — | $74.75 | $74.89 | +0.2% | +2.3% | +4.7% | +7.0% | +7.9% | +7.0% |
| Oct 30 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $77.38 | $77.38 | +0.0% | -3.1% | -3.1% | -3.8% | -4.0% | -2.3% |
| Oct 30 | Wells Fargo | Maintains | Overweight → Overweight | — | $77.38 | $77.38 | +0.0% | -3.1% | -3.1% | -3.8% | -4.0% | -2.3% |
| Oct 30 | Evercore ISI | Maintains | Outperform → Outperform | — | $77.38 | $77.38 | +0.0% | -3.1% | -3.1% | -3.8% | -4.0% | -2.3% |
| Oct 13 | BTIG | Maintains | Buy → Buy | — | $71.01 | $72.02 | +1.4% | +1.2% | +1.9% | +3.1% | +3.3% | +4.3% |
| Oct 7 | Citigroup | Downgrade | Buy → Neutral | — | $76.41 | $75.13 | -1.7% | -2.5% | -1.7% | -2.9% | -7.1% | -6.0% |
| Jul 31 | Citigroup | Maintains | Buy → Buy | — | $71.64 | $72.34 | +1.0% | -0.4% | -2.5% | -1.4% | -1.3% | -2.3% |
| Jul 31 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $71.64 | $72.34 | +1.0% | -0.4% | -2.5% | -1.4% | -1.3% | -2.3% |
| Jul 9 | Citigroup | Maintains | Buy → Buy | — | $75.20 | $75.85 | +0.9% | +0.4% | +1.7% | -0.1% | -1.0% | -1.1% |
| May 6 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $69.37 | $68.48 | -1.3% | -3.3% | -0.8% | +1.6% | +0.7% | +6.8% |
| May 5 | UBS | Upgrade | Sell → Neutral | — | $70.53 | $69.93 | -0.9% | -1.6% | -4.9% | -2.4% | -0.0% | -0.9% |
| May 1 | Goldman Sachs | Maintains | Buy → Buy | — | $70.33 | $70.32 | -0.0% | -3.8% | +0.3% | -1.4% | -4.6% | -2.1% |
| May 1 | Evercore ISI | Maintains | Outperform → Outperform | — | $70.33 | $70.32 | -0.0% | -3.8% | +0.3% | -1.4% | -4.6% | -2.1% |
| May 1 | Wells Fargo | Maintains | Overweight → Overweight | — | $70.33 | $70.32 | -0.0% | -3.8% | +0.3% | -1.4% | -4.6% | -2.1% |
| Apr 30 | Citigroup | Maintains | Buy → Buy | — | $68.09 | $72.50 | +6.5% | +3.3% | -0.6% | +3.6% | +1.9% | -1.5% |
| Apr 23 | Piper Sandler | Maintains | Overweight → Overweight | — | $61.65 | $64.50 | +4.6% | +5.3% | +8.8% | +11.0% | +10.4% | +10.4% |
| Mar 11 | Goldman Sachs | Upgrade | Neutral → Buy | — | $85.36 | $87.34 | +2.3% | +0.3% | -1.8% | -4.6% | -4.0% | -3.4% |
| Feb 14 | Wells Fargo | Maintains | Overweight → Overweight | — | $93.48 | $93.20 | -0.3% | -1.4% | -0.9% | -1.0% | -1.5% | -2.6% |
| Feb 13 | Citigroup | Maintains | Buy → Buy | — | $85.90 | $90.00 | +4.8% | +8.8% | +7.3% | +7.9% | +7.7% | +7.2% |
| Jan 8 | Jefferies | Upgrade | Hold → Buy | — | $83.37 | $84.65 | +1.5% | +3.5% | +1.7% | +2.4% | +0.9% | +0.3% |
| Oct 31 | Wells Fargo | Maintains | Overweight → Overweight | — | $87.20 | $86.12 | -1.2% | +0.2% | -0.3% | -0.2% | +1.1% | -0.5% |
| Oct 1 | Evercore ISI | Maintains | Outperform → Outperform | — | $93.85 | $93.82 | -0.0% | -2.3% | -3.0% | -4.2% | -2.6% | -4.0% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | CULP H LAWRENCE JRDir | — | Buy | 80,805 | $61.88 | $5.0M | 151,207 | +3.47% | — |
| May 6, 2026 | Stromberg William JDir | — | Buy | 1,000 | $61.69 | $62K | 15,330 | +3.47% | — |
| May 1, 2026 | SACCARO JAMESOff | Chief Financial Officer | Buy | 3,310 | $60.60 | $201K | 87,471 | -0.05% | +4.00% |
| Apr 30, 2026 | Arduini Peter JDir/Off | President and CEO | Buy | 4,169 | $59.92 | $250K | 259,424 | +0.31% | +0.82% |
| Apr 30, 2026 | Jimenez Frank ROff | GC & Corporate Secretary | Buy | 1,750 | $60.45 | $106K | 93,932 | +0.31% | +0.82% |
8-K
GE HealthCare Technologies Inc. -- 8-K Filing
GE HealthCare exceeded topline expectations at year-start, with strong growth in Pharmaceutical Diagnostics, Advanced Visualization, and Imaging segments driving performance.
Apr 29
8-K
Unknown — 8-K Filing
I cannot provide meaningful analysis from this filing summary, as it contains only technical XBRL metadata and XML schema references without actual business substance or financial information relevant to GEHC or PH stock performance.
Mar 17
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Kevin A.'s appointment as CEO following Mihaljevic's departure creates leadership uncertainty at GE Healthcare, potentially pressuring the stock until investors assess the new leader's strategic vision and execution capability.
Mar 17
8-K · 1.01
! Medium
GE HealthCare Technologies Inc. -- 8-K 1.01: Financing / Debt Agreement
GE HealthCare replaced its $500 million 364-day revolving credit facility with a new agreement maturing February 2027, providing continued liquidity access through JPMorgan Chase Bank.
Feb 27
8-K
GE HealthCare Technologies Inc. -- 8-K Filing
GE HealthCare exceeded Q4 2025 revenue and EPS expectations with 7.1% total revenue growth and 4.8% organic growth, demonstrating operational momentum as a standalone public company.
Feb 4
Data updated apr 25, 2026 11:06am
· Source: massive.com